As the online celebrations for the International Thalassaemia Day 2020 are at their peak, TIF decided to publish today as a gift to its worldwide patient communities a new guide entitled ”COVID-19 & Haemoglobin Disorders: A Classification of Risk Groups & Other Considerations”.
Patients with thalassaemia and sickle cell disease (SCD) are likely to be at increased risk of complications from the new coronavirus.
TIF has made an effort to classify the level of risk around these patients and bring together published information on risk factors and best practices for their best possible management in the time of the pandemic. These practices and recommendations have been either published in peer-reviewed journals, and/or national government or professional society websites and/or national patient NGOs and include mainly the UK, Germany, France, USA, Italy and Cyprus, and constitute a base on which patients, treating specialists and national authorities should build on further.
Read & Download the Full Guide HERE.